Standout Papers

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma 2007 2026 2013 2019 3.8k
  1. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma (2007)
    Bernard Escudier, Tim Eisen et al. New England Journal of Medicine

Immediate Impact

8 by Nobel laureates 17 from Science/Nature 63 standout
Sub-graph 1 of 17

Citing Papers

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
2022 Standout
Targeting the HIF2–VEGF axis in renal cell carcinoma
2020 StandoutNobel
54 intermediate papers

Works of Michael Siebels being referenced

Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation
2010
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Michael Siebels 3367 2686 613 1580 64 5.2k
Tomasz Demkow 4227 3567 750 2139 76 6.5k
Stephan Störkel 3636 2887 1062 1518 122 5.7k
Neeraj Agarwal 3276 1829 1060 1566 203 4.7k
Zohar Dotan 2512 2234 995 1000 123 5.2k
Eleni Efstathiou 4556 1988 602 2321 201 7.2k
Ingela Turesson 5372 1894 929 2507 118 9.2k
Eunsik Lee 2697 2003 617 1072 61 3.9k
Andrew Protheroe 3171 1763 927 1333 122 5.8k
Louis R. Bégin 1621 1316 740 1603 104 4.6k
Brian Shuch 5018 3602 1269 1342 196 6.7k

All Works

Loading papers...

Rankless by CCL
2026